These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 2460179

  • 1. AH6809, a prostaglandin DP-receptor blocking drug on human platelets.
    Keery RJ, Lumley P.
    Br J Pharmacol; 1988 Jul; 94(3):745-54. PubMed ID: 2460179
    [Abstract] [Full Text] [Related]

  • 2. The classification of prostaglandin DP-receptors in platelets and vasculature using BW A868C, a novel, selective and potent competitive antagonist.
    Giles H, Leff P, Bolofo ML, Kelly MG, Robertson AD.
    Br J Pharmacol; 1989 Feb; 96(2):291-300. PubMed ID: 2924081
    [Abstract] [Full Text] [Related]

  • 3. GR32191, a highly potent and specific thromboxane A2 receptor blocking drug on platelets and vascular and airways smooth muscle in vitro.
    Lumley P, White BP, Humphrey PP.
    Br J Pharmacol; 1989 Jul; 97(3):783-94. PubMed ID: 2527074
    [Abstract] [Full Text] [Related]

  • 4. Thromboxane (Tx) A2 receptor blockade and TxA2 synthase inhibition alone and in combination: comparison of anti-aggregatory efficacy in human platelets.
    Watts IS, Wharton KA, White BP, Lumley P.
    Br J Pharmacol; 1991 Feb; 102(2):497-505. PubMed ID: 1826620
    [Abstract] [Full Text] [Related]

  • 5. Prostaglandin D2 interacts at thromboxane receptor-sites on guinea-pig platelets.
    Hamid-Bloomfield S, Whittle BJ.
    Br J Pharmacol; 1986 Aug; 88(4):931-6. PubMed ID: 3017497
    [Abstract] [Full Text] [Related]

  • 6. Potentiation of aggregation and inhibition of adenylate cyclase in human platelets by prostaglandin E analogues.
    Matthews JS, Jones RL.
    Br J Pharmacol; 1993 Feb; 108(2):363-9. PubMed ID: 8448586
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of ZK110841 and AH6809, an agonist and an antagonist of prostaglandin DP-receptors on human platelets, with a PGD2-responsive cell line from bovine embryonic trachea.
    Ito S, Okuda E, Sugama K, Negishi M, Hayaishi O.
    Br J Pharmacol; 1990 Jan; 99(1):13-4. PubMed ID: 2158830
    [Abstract] [Full Text] [Related]

  • 8. Antagonistic action of AA-2414 on thromboxane A2/prostaglandin endoperoxide receptor in platelets and blood vessels.
    Imura Y, Terashita Z, Shibouta Y, Inada Y, Nishikawa K.
    Jpn J Pharmacol; 1990 Jan; 52(1):35-43. PubMed ID: 2137886
    [Abstract] [Full Text] [Related]

  • 9. Competitive antagonism at thromboxane receptors in human platelets.
    Armstrong RA, Jones RL, Peesapati V, Will SG, Wilson NH.
    Br J Pharmacol; 1985 Mar; 84(3):595-607. PubMed ID: 2580580
    [Abstract] [Full Text] [Related]

  • 10. Interaction of prostaglandin D2 with prostacyclin, carbacyclin and the hydantoin prostaglandin, BW245C, in guinea-pig platelets.
    Hamid S, Whittle BJ.
    Br J Pharmacol; 1985 May; 85(1):285-90. PubMed ID: 2992652
    [Abstract] [Full Text] [Related]

  • 11. The antagonism by BW A868C of PGD2 and BW245C activation of human platelet adenylate cyclase.
    Trist DG, Collins BA, Wood J, Kelly MG, Robertson AD.
    Br J Pharmacol; 1989 Feb; 96(2):301-6. PubMed ID: 2466517
    [Abstract] [Full Text] [Related]

  • 12. The PGI2-analogue iloprost and the TXA2-receptor antagonist sulotroban synergistically inhibit TXA2-dependent platelet activation.
    Stürzebecher S, Witt W.
    Prostaglandins; 1988 Dec; 36(6):751-60. PubMed ID: 2469101
    [Abstract] [Full Text] [Related]

  • 13. Prostaglandins and human platelet aggregation. Implications for the anti-aggregating activity of thromboxane-synthase inhibitors.
    Rajtar G, Cerletti C, Castagnoli MN, Bertelé V, de Gaetano G.
    Biochem Pharmacol; 1985 Feb 01; 34(3):307-10. PubMed ID: 3918536
    [Abstract] [Full Text] [Related]

  • 14. Characterization of the prostanoid receptor(s) on human blood monocytes at which prostaglandin E2 inhibits lipopolysaccharide-induced tumour necrosis factor-alpha generation.
    Meja KK, Barnes PJ, Giembycz MA.
    Br J Pharmacol; 1997 Sep 01; 122(1):149-57. PubMed ID: 9298541
    [Abstract] [Full Text] [Related]

  • 15. Antiplatelet effects of the novel thromboxane A2 receptor antagonist sodium (E)-11-[2-(5,6-dimethyl-1-benzimidazolyl)-ethylidene]-6,11- dihydrodibenz[b,e] oxepine-2-carboxylate monohydrate.
    Karasawa A, Kawakage M, Shirakura S, Higo K, Kubo K, Ohshima E, Obase H.
    Arzneimittelforschung; 1991 Dec 01; 41(12):1230-6. PubMed ID: 1840011
    [Abstract] [Full Text] [Related]

  • 16. Effects of the P2-purinoceptor antagonist, suramin, on human platelet aggregation induced by adenosine 5'-diphosphate.
    Hourani SM, Hall DA, Nieman CJ.
    Br J Pharmacol; 1992 Feb 01; 105(2):453-7. PubMed ID: 1559134
    [Abstract] [Full Text] [Related]

  • 17. Prostaglandin DP receptors positively coupled to adenylyl cyclase in embryonic bovine tracheal (EBTr) cells: pharmacological characterization using agonists and antagonists.
    Crider JY, Griffin BW, Sharif NA.
    Br J Pharmacol; 1999 May 01; 127(1):204-10. PubMed ID: 10369474
    [Abstract] [Full Text] [Related]

  • 18. Characterization of the inhibitory prostanoid receptors on human neutrophils.
    Wheeldon A, Vardey CJ.
    Br J Pharmacol; 1993 Apr 01; 108(4):1051-4. PubMed ID: 8387383
    [Abstract] [Full Text] [Related]

  • 19. Pharmacological characterization of thromboxane and prostanoid receptors in human isolated urinary bladder.
    Palea S, Toson G, Pietra C, Trist DG, Artibani W, Romano O, Corsi M.
    Br J Pharmacol; 1998 Jul 01; 124(5):865-72. PubMed ID: 9692770
    [Abstract] [Full Text] [Related]

  • 20. Pharmacological characterization in vitro of prostanoid receptors in the myometrium of nonpregnant ewes.
    Crankshaw DJ, Gaspar V.
    J Reprod Fertil; 1995 Jan 01; 103(1):55-61. PubMed ID: 7535849
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.